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Abstract
Background: Intraoperative radiotherapy (IORT) is promising approach that is being tested in
randomised clinical trials. In the Targit (TARGeted Intraopeartive radioTherapy) trial IORT can be
delivered at the time of primary surgery or as a second procedure. Patients prefer the single
procedure of intraoperative radiotherapy even if it is under general anaesthetic to 6-weeks of daily
visits for conventional external beam radiotherapy.
Case presentation: We report a case of a 70 year lady who underwent lumpectomy and axillary
sampling and in whom we successfully administered IORT under local anaesthetic.
Conclusion: In selected patients, this attractive option may make the procedure even more widely
applicable.
Background
Partial breast irradiation for breast cancer is being tested
in randomised trials[1]. In the TARGIT trial [2] patients
can receive the TARGeted Intraoperative radioTherapy
either during the primary operation or as a second proce-
dure. Over 300 patients have been randomised in this
multi-centre trial to date.
Case presentation
A 70 year old lady who had a lumpectomy and axillary
sample for a 2.8 cm, grade II, node-negative breast cancer
was with her consent, entered into the trial. She was ran-
domised to receive intraoperative radiotherapy as a sec-
ond procedure. However, the attending anaesthetist felt
that because of the history of severe ischaemic heart dis-
ease a second general anaesthetic should be avoided. The
patient was keen to take the intraoperative radiotherapy to
which she was randomised, rather than come every day
for radiotherapy for 6 weeks; she was willing to undergo
the whole procedure under local anaesthetic.
She received temazepam (10 mg), preoperatively. She was
given midazolam 1 mg i.v. just prior to infiltration of the
scar (just the skin) with 1% lignocaine with 1:200,000
adrenaline and 0.5% marcaine in a ration of 1:1. During
the infiltration she breathed a 50:50 mixture of oxygen
and nitrous oxide, followed by oxygen @ 6 L/min via
Hudson mask.
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The patient (eyes open) and the Intrabeam device Figure 1
The patient (eyes open) and the Intrabeam device. The breast is covered with lead shield (blue). [the patient has given explicit 
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The cavity was opened and radiotherapy applicator posi-
tioned with a purse string suture as usual. The patient did
not feel any pain and tolerated the procedure well (figure
1). She remained still during the 22 minutes while radio-
therapy (20 Gy at surface) was delivered to the tumour
bed (figure 2). Postoperative period was uneventful and
we discharged home a happy patient.
Discussion
Delivering intraoperative radiotherapy ("targiting") as a
second procedure allows proper selection of patients
because detailed histopathology is available. The
approach can also extend the applicability of intraopera-
tive radiotherapy to patients who have already had opera-
tion in other centres.  The Targit technique with
Intrabeam(TM) delivers radiotherapy  from within the
tumour bed and does not require extensive dissection of
breast tissue; it is therefore feasible under a local anaes-
thetic. If the Targit trial is successful, it is likely that many
suitable patients will have significant co-morbidities and
a second general anaesthetic would be ideally avoided. It
appears that this is possible in selected patients.
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The spherical applicator is inserted in the tumour bed and the target breast tissue is wrapped around with a purse string Figure 2
The spherical applicator is inserted in the tumour bed and the target breast tissue is wrapped around with a purse string.